A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study [PDF]
Terzah M. Horton +18 more
openalex +1 more source
Brentuksimab Vedotin Treatment in Relaps Refractory Hodgkin Lymphoma: A Single Center Experience
Derya Koyun +12 more
openalex +1 more source
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
J. Connors +28 more
semanticscholar +1 more source
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino +10 more
wiley +1 more source
Soluble cytokines enhance risk prediction across all stages of classical Hodgkin lymphoma. [PDF]
Kredátusová A +13 more
europepmc +1 more source
ABSTRACT Objectives To determine the diagnostic value of disclosing monotypic T‐cell populations by expression analysis of the constant region 1 of T‐cell receptor β (TRBC1) by flow cytometry, for the detection of T‐cell neoplasms, in a routine hematopathology practice setting.
Nilofar Rajabian +4 more
wiley +1 more source
Cholestatic Jaundice as the Initial Manifestation of Classical Hodgkin Lymphoma: A Diagnostic Challenge. [PDF]
Grossmann I +4 more
europepmc +1 more source
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
P. Johnson +20 more
semanticscholar +1 more source
Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders [PDF]
Chen, Chun-Cheng +8 more
core +2 more sources

